Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Next-generation Sequencing Market Expected Growth of 20.9% During the Forecast Period, 2019-2025 - ResearchAndMarkets.com

December 24, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Dec 24, 2019--

The “Next-generation Sequencing (NGS) Market by Product (NOVASEQ, NEXTSEQ, SEQUEL, NANOPORE), Consumables, Bioinformatics, Services (EXOME, RNA, DENOVO), Technology (ION, SMRT), Application (Diagnostics, Cancer), End User, Region - Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.

The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%.

The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period

The growth of this market is largely driven by advancements in and the declining costs of NGS platforms and the improving regulatory and reimbursement scenario for NGS-based diagnostic tests. The NGS market is segmented based on application, technology, product & service, end user, and region.

The SBS segment accounted for the largest share of the NGS market in 2018

On the basis of technology, the NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, nanopore sequencing, and other sequencing technologies. In 2018, the SBS segment accounted for the largest share of the NGS market. The dominant market position of this segment is mainly due to the development of new and advanced NGS platforms and the increasing demand for Illumina’s systems, as it is the major provider of SBS-based NGS platforms (including the HiSeq MiSeq series and NextSeq).

The diagnostics application segment accounted for the largest share of the NGS market in 2018

Based on applications, the NGS market is segmented into diagnostics, drug discovery, agricultural & animal research, and other applications, which include marine research and research in biofuels, forensics, metagenomic studies, and evolutionary studies. Of all these application segments, diagnostics accounted for the largest share of the NGS market in 2018. The large share of this segment can be attributed to the growing number of new cancer cases across the globe, favorable reimbursement scenario for NGS-based tests in the US, and increasing focus of key market players on developing NGS-based products & services for cancer and NIPT.

North America accounted for the largest share of the NGS market in 2018

North America accounted for the largest share of the NGS market in 2018, followed by Europe. This can primarily be attributed to factors such as the increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions.

Key Benefits of Buying the Report

This report focuses on various levels of analysis - industry trends, market shares of top players, and company profiles, which together form basic views. It also analyzes the competitive landscape; emerging segments of the NGS market; and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Key Topics Covered:

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Market Scope

1.4 Currency

1.5 Limitations

1.6 Stakeholders

2 Research Methodology

2.1 Research Data

2.2 Market Size Estimation

2.3 Market Breakdown & Data Triangulation

2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights

4.1 Next-Generation Sequencing Market Overview

4.2 Next-Generation Sequencing Market, By Product & Service, 2019 vs 2025 (USD Million)

4.3 Next-Generation Sequencing Market Share, By Technology, 2019 vs 2025

4.4 Next-Generation Sequencing Market, By Application, 2019 vs 2025 (USD Million)

4.5 Next-Generation Sequencing Market, By End User, 2019 vs 2025 (USD Million)

4.6 Next-Generation Sequencing Market: Geographical Snapshot

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

6 Next-Generation Sequencing Market, By Product & Service

6.1 Introduction

6.2 Presequencing Products & Services/Sample Preparation

6.3 NGS Consumables

6.4 NGS Platforms

6.5 Services for NGS Platforms

6.6 Sequencing Services

6.7 Bioinformatics

7 Next-Generation Sequencing Market, By Technology

7.1 Introduction

7.2 Sequencing By Synthesis

7.3 Ion Semiconductor Sequencing

7.4 Single-Molecule Real-Time Sequencing

7.5 Nanopore Sequencing

7.6 Other Sequencing Technologies

8 Next-Generation Sequencing Market, By Application

8.1 Introduction

8.2 Diagnostics

8.3 Drug Discovery

8.4 Agricultural & Animal Research

8.5 Other Applications

9 Next-Generation Sequencing Market, By End User

9.1 Academic Institutes & Research Centers

9.2 Hospitals & Clinics

9.3 Pharmaceutical & Biotechnology Companies

9.4 Other End Users

10 Next-Generation Sequencing Market, By Region

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 Latin America

10.6 Middle East & Africa

11 Competitive Landscape

11.1 Introduction

11.2 Competitive Leadership Mapping

11.2.1 Terminology/Nomenclature Visionary Leaders Innovators Dynamic Differentiators Emerging Companies

11.3 Competitive Scenario (2015-2019)

11.4 NGS Market Ranking, By Top Three Market Players (2018)

12 Company Profiles

12.1 Agilent Technologies, Inc.

12.2 Illumina, Inc.

12.3 Qiagen N.V.

12.4 F. Hoffmann-La Roche AG

12.5 Thermo Fisher Scientific, Inc.

12.6 Genewiz (A Part of Brooks Automation)

12.7 BGI Group

12.8 Perkinelmer

12.9 Eurofins Scientific

12.10 Macrogen.

12.11 Oxford Nanopore Technologies

12.12 10x Genomics

12.13 Takara Bio

12.14 Zymo Research

12.15 Nugen Technologies (Part of Tecan Trading AG)

12.16 Hamilton Company

12.17 Beckman Coulter (A Subsidiary of Danaher)

12.18 Becton, Dickinson and Company

12.19 Genotypic Technology

12.20 Lucigen Corporation

For more information about this report visit https://www.researchandmarkets.com/r/11zc50

View source version on businesswire.com:https://www.businesswire.com/news/home/20191224005130/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 12/24/2019 08:27 AM/DISC: 12/24/2019 08:27 AM